Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elevated Health vs PlexusDx

Elevated Health
Graded #283

Lower grade

vs+5.900000000000006
PlexusDx
Graded #158

Higher grade

The verdict

PlexusDx takes it — 67.7/100 to 61.8/100.

PlexusDx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PlexusDx (plexusdx.com) is a US GLP-1 telehealth platform offering compounded weight-loss medications with licensed providers in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePlexusDx +37
37
74
Dose & formulationElevated Health +24
88
64
Clinical oversightEven
74
74
Labs & monitoringEven
52
52
FulfillmentPlexusDx +16
62
78
Contract termsElevated Health +6
61
55
Elevated Health · left barPlexusDx · right bar

The numbers

MetricElevated HealthPlexusDx
WeighScore61.8/10067.7/100
GradeCC
Scorecard rank#283#158
Semaglutide$296/mo (compounded)$149/mo (starting dose, compounded)
Tirzepatide$359/mo (compounded)$249/mo (starting dose, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Elevated Health

Graded #283 · C

Strengths

  • $100 off first month
  • Oral semaglutide option
  • Competitive pricing — compounded semaglutide from $187/mo (12-month plan), tirzepatide from $235/mo

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity or address disclosed
  • State availability not disclosed
  • Shopify storefront — few clinical infrastructure signals
PlexusDx

Graded #158 · C

Strengths

  • Licensed providers available in all 50 states
  • Range of options including low-cost microdose GLP-1 from $129/mo
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

Where it loses points

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • Tirzepatide pricing from $249/mo is higher than budget rivals
  • No insurance accepted

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard